Advisory Committee; Anesthetic and Analgesic Drug Products Advisory Committee, Renewal

ローカル自動翻訳 · 情報源の原言語

概要

The Food and Drug Administration (FDA) is announcing the renewal of the Anesthetic and Analgesic Drug Products Advisory Committee (the Committee) by the Commissioner of Food and Drugs (the Commissioner). The Commissioner has determined that it is in the public interest to renew the Committee for an additional 2 years beyond the charter expiration date. The new charter will be in effect until May 1, 2020.

情報源の原言語: Federal Register — Food and Drug Administration原文の発表を開く →

Advisory Committee; Anesthetic and Analgesic Drug Products Advisory Committee, Renewal

Office of Management and Budget (OMB) に提出された情報収集活動; Food and Drug Administration (FDA) の提出書類の提出; Customer/Partner Customer Service Satisfaction Surveys に関するコメントの要求

Office of the National Coordinator for Health Information Technology; Health Information Technology Advisory Committee; エンタイントにそすにしたプログルにしたプログにプログを定义にしたプログに。